Skip to search formSkip to main contentSkip to account menu

tazarotene

Known as: tazarotene [Chemical/Ingredient], Ethyl 6-(2-(4,4-Dimethylthiochroman-6-yl)ethynyl)nicotinate, 6-[(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]- 3-Pyridinecarboxylic Acid, Ethyl Ester 
A drug used on the skin to treat several skin conditions. It is also being studied in the treatment of basal cell skin cancer and basal cell nevus… 
National Institutes of Health

Related topics

Related topics

16 relations

Narrower (3)

AGN 190168AvageTazorac
Acne VulgarisDrug AllergyImmunologic and Biological Factors [MoA]NCIt Antineoplastic Agent Terminology

Broader (4)

Dermatologic AgentsKeratolytic AgentsNicotinic AcidsTeratogens

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
La photothérapie UVB à spectre étroit dans le psoriasis vulgaire: utilisation pratique et préconisations de la Société Française de Photodermatologie
2009
2009
Role of the RARRES1 gene in nasopharyngeal carcinoma.
Review
2004
Review
2004
Current management strategies for cutaneous T-cell lymphoma.
Review
2004
Review
2004
Retinoid therapy for psoriasis.
Highly Cited
2004
Highly Cited
2004
Topical tazarotene: The BEST (balancing efficacy, speed, and tolerability) in acne trial.
Results of clinical trials have shown that tazarotene cream used as monotherapy effectively reduces the number of both… 
Highly Cited
2002
Highly Cited
2002
Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial.
The efficacy and tolerability of tazarotene 0.1% gel and tretinoin 0.1% microsponge gel were evaluated in a multicenter, double… 
Highly Cited
2001
Highly Cited
2001
Investigator‐masked comparison of tazarotene gel q.d. plus mometasone furoate cream q.d. vs. mometasone furoate cream b.i.d. in the treatment of plaque psoriasis
Seventy‐three patients with stable plaque psoriasis entered an investigator‐masked trial comparing once‐daily tazarotene 0.1% gel… 
Review
2000
Review
2000
Strategies to optimize efficacy, duration of remission, and safety in the treatment of plaque psoriasis by using tazarotene in combination with a corticosteroid.
In the treatment of plaque psoriasis with corticosteroids, long-term efficacy and safety are often compromised by tachyphylaxis… 
Highly Cited
1999
Highly Cited
1999
Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis
Although tazarotene monotherapy is generally efficacious and well tolerated, studies show that both the efficacy and the… 
Review
1998
Review
1998
Rational design of receptor-selective retinoids.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)